More research is needed to understand the neurophysiological changes in the brain that occur when we’re awake during the circadian night.
Blog
The good news is that most strokes are preventable, treatable and beatable, says Natalia Rost, MD, MPH, Chief of the Stroke Division.
A new study shows that the exercise hormone irisin confers the cognitive benefits of exercise on the brain and could be a new therapeutic option for Alzheimer’s disease.
In the second installment, we highlight two more approaches to Alzheimer’s research with Drs. Susanne Janneke Van Veluw and Mehdi Jorfi.
Learn how Mass General researchers are working to develop new treatments and diagnostic tools for Alzheimer’s disease and dementia.
Hoang Le, PhD, is a postdoctoral research fellow in the Genetics and Aging Research Unit.
James Quinn, PhD, is a researcher in the Alzheimer’s Clinical and Translational Research Unit (ACTRU) studying the mechanisms underlying dementia development to identify new biomarkers and novel therapeutic targets, focusing on the signaling molecules, neuropeptides. Outside the lab, James is an avid science communicator, rock climber and live music enthusiast. We all have been there—standingRead more
Genetics & Genomics, Researcher Profiles, Sleep Disorders, Voices of Women In Science, Women in Science | 0 comment | 16 March, 2021 | 0
Jacqueline Lane, PhD, is a sleep genetics and circadian rhythms researcher investigating the connections between sleep quality and disease.
Alzheimer's Disease, Cardiology, Depression, Endowed MGH Research Institute Chairs | 0 comment | 23 February, 2021 | 1
The COVID-19 pandemic is only the most recent example of the central role that sex and gender play in major medical illness.
Andrea Harriott, MD, PhD, is a neurology researcher at studying the connection between migraine and stroke and the impact these conditions have on Black women.